Invagen | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

102 results for “Invagen”

Trials

View all 48 →

Antifungal Use in Oncohematological Neutropenic Patients

115 participants · First posted Oct 12, 2006

Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19

72 participants · First posted Mar 22, 2021

Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy

80 participants · First posted Jun 19, 2025

Drugs

View all 28 →

INCAGN-1949

Liraglutide biosimilar(Cinnagen)

Teriparatide biosimilar (CinnaGen)

Organizations

View all 16 →

InvaGen Pharmaceuticals Inc.

United States

NIVAGEN PHARMACEUTICALS, INC.

United States

CINNAGEN

Iran

News

View all 10 →

USFDA Classifies Cipla's InvaGen New York Unit 3 Inspection as Voluntary Action Indicated

Cipla Secures Exclusive Rights to HER2 Bispecific ADC TQB2102 Across Seven Emerging Markets

Federal Circuit Rules "Clinically Proven Effective" Claims Cannot Rescue Anticipated Drug Methods from Prior Art

Page 1 of 11